we're building China's first healthcare REIT, can you help?

This is a chance to do good in the world, save some lives, and make an impact.

4 years ago I and a couple partners created a private hospital company in China.
We acquired our first hospital, and then last year, acquired the second hospital.
We raised and invested about $100mn.
Now we're running into some struggles.
We have sunk a lot of money into physical property and capex.
Property in the area has doubled in value, so we're sitting on a fair bit of equity value.
We have no debt.
The hospital is organized as a holdco, owning an opco, owning a propco.
We employ 150 staff, mostly physicians.
We have thousands of patients see us, but still too few to be anywhere close to break even.
We're mulling over some potential next steps, including:

  • raising traditional bank debt, collateralized by pledges of the hospital properties

  • we are currently in process of separating the opco and propco with the aim of creating China's first healthcare REIT. The idea is to give lower-yield investors who want the security of investing in real estate to invest in the hospitals. The hospital opco would then be a separate company, running the hospitals. The opco is what most of the growth capital funds we've spoken to are interested investing into, because it's more asset light and would likely be more rapidly growing

  • we could raise a SPAC perhaps -something suggested by one of the folks in WSO. I know nothing about this path though

  • so far, raising money for this entity (beyond the $100mn) has been challenging.

I am interested in getting helpful advice on how we should steer this ship.
I'd be especially keen to hear from those on the WSO who have hospital experience or healthcare IBD or PE, so I can bounce ideas.
This is a chance to do good in the world, save some lives, and make an impact.

 

Hey GI, Historically most of the healthcare has been public, but about 6 years ago the gov started a nationwide healthcare reform policy. That policy has been comprehensive, across pharma, device, delivery, insurance. One of the reasons we've been able to buy the hospitals relatively cheaply is because the government has been selling off select public hospital properties in order to accelerate the private hospital market, and set up a second pathway for healthcare delivery. There are many specialist and generalist hospitals. Our hospitals are private. The smaller one (100 beds) is open and does outpatient, inpatient, and surgeries (mostly ortho). We have a 450 bed hospital that is undergoing renovations and won't be open until 2020.

 

For getting a job in Asia, assuming you have the requisite language skills you can try the following. 1) apply for jobs and contact recruiters at efinancialcareers.com.hk 2) come to Asia during summer, winter or spring break and try to tag along with the MBA 'days on the job' corporate presentations 3) do internships in Asia. Apply to companies directly to get those, or check efinancialcareers as noted above.

 

I'm not super experienced in this, but interested in what you're doing. A few questions I have in general that may/may not be helpful:

  1. are you looking for onshore RMB investments? How would USD investors come in - seeing tax issues and questions on getting capital offshore? Rqfii channel?
  2. regionally where are these underlying properties? Is it collateralized on real estate or equipment or both?
  3. What is the current investor base? I'm assuming it's mostly onshore investors.
  4. Not sure if this will be relevant for a REIT, but from a debt perspective, if there is a "default" of any kind, what are the convenants around it? Aka, what is the disaster recovery case?

And my last question is market concerns in general, not related to the structure: how do you make the case for Chinese hospital real estate? Many literature out there is calling a bubble on Chinese real estate.

 
  1. are you looking for onshore RMB investments? How would USD investors come in - seeing tax issues and questions on getting capital offshore? Rqfii channel?

> we can take either/both, as we have onshoring capability through approved QFLP allocation

  1. regionally where are these underlying properties? Is it collateralized on real estate or equipment or both?

> our two hospitals are both in a tier 2 city in the Pearl River Delta in Guangdong

  1. What is the current investor base? I'm assuming it's mostly onshore investors.

> a mix of onshore and offshore individual investors, and a 30% stake sold to a publicly listed healthcare company

  1. Not sure if this will be relevant for a REIT, but from a debt perspective, if there is a "default" of any kind, what are the convenants around it? Aka, what is the disaster recovery case?

> no idea

And my last question is market concerns in general, not related to the structure: how do you make the case for Chinese hospital real estate? Many literature out there is calling a bubble on Chinese real estate. [/quote]

> Well we bought several years ago, so we're up 2x. Can't just jettison the hospitals we already bought just because of short-term valuation movements. We're building a company, not short-term investors.

 

I'm a CDO manager working in China. I'm curious about the structure of your REIT. Do you plan to structure the REIT in China or overseas market? As you may know, China does not have REIT as a legal concept. To create a REIT, you'll need to set up a private fund to buy the building or to write loans to the hospital, then repackage the shares of the fund into an ABS to be traded in the exchange. We call it quasi-REIT. But in the current regulation, exchanges might not approve the issuance of healthcare quasi-REITs, especially not with assets of a start-up as collateral.

 
Most Helpful

earthwalker7 I PM'd you already, as I'm definitely game for discussion.

I would explore an MLP structure as well. If you're running this as an NFP, I don't think you'll see much value from a Tax standpoint with either the MLP or the REIT. With a REIT, you'll need to change the entire structure so that the hospital leases the facilities from a TRS. The catch is that the TRS needs to be managed by an independent 3rd party. Then there's also the loss of control on the real assets. That may be a problem, especially on appreciating property values. With an MLP, you can retain ownership through a GP/LP structure and sell the LP shares on the market. The MLP has flexibility in distributions (governed by the partnership agreement and not regulation), strong control and good potential for growth, but has an underlying tax issue - being taxed more than you should. Are you looking to do this (a REIT or MLP) on the US Market or the Chinese markets? I think the strategy changes depending on how you handle that. I don't know the regulations in China, but if HoggieT is right, doing it in China as opposed to the US may be harder to do. Following the US structure may be easier.

As far as growing the business from the services side, I know nothing about insurance and reimbursement in China and have a few questions about the T2 cities you're in. Are these large cities (Think major cities in a T2 region) or smaller areas? Are the hospitals the equivalent of a Level I/Level II Trauma center in the US or are they Level III/Level IV. Are all the surgeries performed done by hospitalists or is there a private practice component? I know you said your caseload is mostly Ortho, but can you be a bit more specific (ie Joint vs. Ortho-Spine vs. Ortho-Trauma)? Are you looking at expanding the surgical mix, as that can drive revenue, increased patient care, Likewise, are you looking at same-day outpatient treatment centers as well? I know, tons of questions,

 

I don't know if the REIT or the MLP can be done. I think that if you do them, it ends up being all offshore funding. As I said, let's move this to PM because I think we'll get way off track on this discussion since there is so much to discuss.

 

We have advisors. Both lawyers and bankers. And most of us ourselves were senior bankers and PE professionals. The chairman was head of China for a big Wall St. ibank, before starting and running their China PE practice. But this is not so easy a case to raise for. Reality is often more difficult than textbook. We also do have lawyers, but they can't really advise on the best locations for getting capital. Lawyers are documenters.

 

I can give my 0.02 but it wont be much. Honestly raising capital should be basically a lost cause at this point, so debt might logically be the next move. A SPAC would be a good alternative. However, regarding debt, I am not sure if you will be able lever up without paying fierce interest rates due to the uncertainty surrounding any general business in China and the riskiness of businesses in the healthcare space. It could be worth a go, but if you down the debt path prepare to shop around a lot.

Dayman?
 

Perspiciatis voluptas et saepe distinctio libero aliquid et. Rerum et sit sed aut non. Blanditiis beatae labore ut laboriosam cumque et voluptatem incidunt. Sit quas debitis beatae quam cumque possimus eos.

Ut quis voluptas voluptas quos nemo tempore ut et. Laboriosam hic aliquam et magnam cum. Qui fugit ea dignissimos eos ea. Ex eum illo qui molestiae.

Debitis eum hic debitis aspernatur quidem repellendus voluptatem fuga. Est reprehenderit velit earum sit labore voluptatem. Ipsa odio animi et et. Aut similique est voluptas incidunt amet velit sapiente. Molestiae praesentium hic mollitia quo in. Quasi in tempora ut consequuntur.

 

Sit non blanditiis tenetur aut beatae illum molestiae qui. Et ut dolorem ipsam.

Recusandae earum sint molestias dolor quod. Nostrum dolorem atque id et maiores tempore. Vel aut sunt tempora velit. Cum eos ipsa libero voluptate molestiae qui similique. Est et voluptas earum voluptatum cumque corrupti sit. Cum quisquam alias aut unde.

Blanditiis nihil magnam repudiandae numquam asperiores velit aut distinctio. Eveniet delectus nisi nihil facere id sit voluptatem. Dignissimos ut soluta velit labore eius harum. Et sapiente quae sint vel.

Consequatur accusamus unde sunt sint et quasi culpa eum. Aut aliquid non dolores voluptatibus sit et eum. Dolores sit aperiam et veniam corporis libero.

Dayman?

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Lazard Freres No 98.8%
  • Goldman Sachs 18 98.3%
  • Harris Williams & Co. New 97.7%
  • JPMorgan Chase 04 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (21) $373
  • Associates (91) $259
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (68) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
Secyh62's picture
Secyh62
99.0
5
kanon's picture
kanon
98.9
6
dosk17's picture
dosk17
98.9
7
GameTheory's picture
GameTheory
98.9
8
CompBanker's picture
CompBanker
98.9
9
Linda Abraham's picture
Linda Abraham
98.8
10
DrApeman's picture
DrApeman
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”